Mark J. Eisenberg, MD MPH FACC FAHA 5

5/1/2012
19
Mark J. Eisenberg, MD MPH FACC FAHA
36. Mak KH, Eisenberg MJ, Eccleston DS, Cornhill JF, Topol EJ. Reuse of coronary
angioplasty equipment: technical and clinical issues. Am Heart J 1996; 131:624-30.
37. Shiuey Y, Eisenberg MJ. Cardiovascular effects of commonly used ophthalmic
medications. Clin Cardiol 1996; 19:5-8.
38. Eisenberg MJ, Califf RM, Cohen EA, Adelman AG, Keeler G, Mark DB, Topol EJ. Use
of evidence-based medical therapy in patients undergoing percutaneous coronary
revascularization: A comparison of practice patterns in the United States, Europe, and
Canada. Am J Cardiol 1997; 79:867-72.
39. Roy D, Talajic M, Thibault B, Dubuc M, Nattel S, Eisenberg MJ, Ciampi A, et al. The
Canadian trial of atrial fibrillation (CTAF): Pilot study and research protocol. Am J
Cardiol 1997; 80:464-8.
40. Mak KH, Challapalli R, Eisenberg MJ, Anderson KM, Califf RM, Topol EJ. Effect of
platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during
percutaneous revascularization of aortocoronary saphenous vein grafts. Am J Cardiol
1997; 80:985-8.
41. Eisenberg MJ, Garzon P. Comparison of cardiology training programs in Canada and
the United States. Am J Cardiol 1998; 82:544-6.
42. *Benzaquen B, Eisenberg MJ, Nguyen T, Challapalli R, Topol EJ. Correlates of inhospital
costs for patients undergoing abdominal aortic aneurysm repair. Am Heart J
1998; 136:696-702.
43. *Garzon P, Eisenberg MJ. Variation in the mineral content of commercially available
mineral waters: Implications for health and disease. Am J Med 1998; 105:125-30.
44. McClellan M, Kessler D for the TECH Investigators. A global analysis of technological
change in health care: The case of heart attacks. Health Affairs 1999; 18:250-5.
45. *Fagih B, Eisenberg MJ. Reuse of angioplasty catheters and the risk for Creutzfeldt-
Jakob disease. Am Heart J 1999; 37:1173-8.
46. *Shaw JP, Eisenberg MJ, Azoulay A, Nguyen N. Reuse of catheters for percutaneous
transluminal coronary angioplasty: Effects on procedure time and clinical outcomes.
Cathet Cardiovasc Intervent 1999; 48:54-60.
47. Kluger DM, Eisenberg MJ, Lindeheimer JH, Chatterjee K, Shiller NB. Serial
echocardiography and the timing of surgery in patients with chronic mitral regurgitation.
J Noninv Cardiol 1999; 3:1-4.
48. Mak KH, Eisenberg MJ, Shaw J. Cost efficacy modeling of functional testing with
perfusion imaging to detect asymptomatic restenosis following percutaneous transluminal
coronary angioplasty. Cathet Cardiovasc Intervent 1999; 48:352-6.
49. Eisenberg MJ, Taylor JM, Cove CJ, Brown KJ, Ellis SG, Topol EJ. Comparison of
percutaneous coronary revascularization costs among HMO and non-HMO cardiologists
practicing in the same institution. J Cardiovasc Diagn Proc 1999; 16:87-97.